Skip to main content
Caplight Logo









ElegsLab

ElegsLab

Private
BusanHealthcare & Life Scienceshttps://www.elegslab.com/

Last Round

Angel

Jan 28, 2025

Company Overview

ElegsLab operates in Healthcare & Life Sciences and is based in Busan. Its latest recorded funding round was an Angel round in January 2025.

ElegsLab is a biotechnology company that provides an AI-driven drug discovery and preclinical CRO platform utilizing microfluidic biochips and C. elegans models.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

ElegsLab Comparables

Compare ElegsLab with similar companies based on industry and business-model similarity.

ElegsLab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NemaLife
87%
vivoVerse
86%
Magnitude Biosciences
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

ElegsLab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelJan 28, 2025
SeedDec 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

ElegsLab Investors

Notable investors and investment history

ElegsLab investors
InvestorRounds
Busan United Technology HoldingsAngel, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2024

    Seed round led by Busan United Technology Holdings.

Book a demo to see all signals

For institutional investors. Book with your work email.

ElegsLab Filings

Explore SEC and related filing metadata, where available.

ElegsLab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about ElegsLab's valuation, stock price, and market status.

Is ElegsLab a public or private company?

ElegsLab is a private company.

What is the current stock price of ElegsLab?

ElegsLab is a private company, so its shares have no public market price. Caplight tracks ElegsLab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ElegsLab worth (valuation)?

Valuation information for ElegsLab is not publicly available.

Can I buy ElegsLab stock?

ElegsLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ElegsLab's last funding round?

ElegsLab's most recent funding round was Angel on January 28, 2025.

Who are the main investors in ElegsLab?

Key investors in ElegsLab include Busan United Technology Holdings.

Will ElegsLab IPO soon?

No public IPO plans have been announced for ElegsLab.

How can I track ElegsLab secondary market activity?

Caplight tracks bids, offers, and trades in ElegsLab's shares on secondary markets.

Firmographic Details

HeadquartersBusan
Year Founded2023
Last FundingJan 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?